Breast Cancer Research Group Presents Work in San Antonio

The Breast Cancer Research Group in the division of Hematology/Oncology in the Department of Medicine is dedicated to improving and extending the lives of patients. As such, there are several different programs under the umbrella of the Breast Cancer Research Program. Drs. Anne Moore, Ellen Chuang, Tessa Cigler and Linda Vahdat comprise this group of medical oncologists who treat breast cancer patients exclusively. They also have a dedicated team of research and clinical practice personnel united under the same goal.

The Breast Cancer Research group recently presented their research at The San Antonio Breast Cancer Meeting, which is the preeminent breast cancer meeting in the world. At this global meeting of breast cancer researchers, which took place from December 10-14, researchers tackle everything in breast cancer; from risk factor for the development of breast cancer, to surgery and new treatments, as well as survivorship issues. The group presented 4 posters this year at the 2008 meeting. They represent their commitment to the NY Cancer Consortium, the development of new drugs, as well as an innovative home-grown way to prevent metastases.

The posters presented at the meeting were the following:

The Effect of Tetrathiomolybdate on Circulating Endothelial Progenitor Cells in Patients with Breast Cancer at High Risk of Recurrence

Phase I-II study of the histone deacetylase inhibitor vorinostat plus paclitaxel and bevacizumab in patients with metastatic breast cancer

A prospective characterization of the resolution of ixabepilone induced peripheral neuropathy from data from a large registration program in patients with metastatic breast cancer

Ixabepilone plus capecitabine vs. Capecitabine in patients with metastatic breast cancer receiving ixabepilone in the first line setting: a pooled analysis from two phase III studies

Top of page